Related Experiment Videos
Behavior in the Lesch--Nyhan syndrome.
Journal of Autism and Childhood Schizophrenia
|September 1, 1976
Summary
Lesch-Nyhan syndrome is an X-linked disorder affecting uric acid metabolism, causing neurological issues and compulsive self-harm. Management focuses on restraint, with new behavioral and pharmacologic therapies showing promise.
Area of Science:
- Biochemistry
- Genetics
- Neurology
Background:
- Lesch-Nyhan syndrome is a rare, inherited metabolic disorder.
- It is characterized by excessive uric acid production and severe neurological and behavioral symptoms.
- The disorder is X-linked, affecting males exclusively.
Purpose of the Study:
- To outline the clinical and molecular aspects of Lesch-Nyhan syndrome.
- To discuss current management strategies for the behavioral manifestations.
- To explore emerging therapeutic approaches for the syndrome.
Main Methods:
- Review of existing literature on Lesch-Nyhan syndrome.
- Analysis of the genetic basis and enzyme deficiency (hypoxanthine guanine phosphoribosyl transferase).
- Description of clinical features, including neurological and behavioral abnormalities.
Main Results:
- Defective hypoxanthine guanine phosphoribosyl transferase activity leads to hyperuricemia and gout-like symptoms.
- Neurological deficits include mental retardation, spasticity, and choreoathetoid movements.
- Compulsive, aggressive behavior, particularly self-mutilation, is a hallmark feature.
Conclusions:
- Lesch-Nyhan syndrome presents complex challenges in patient management.
- Physical restraint is a primary method for managing self-harm behavior.
- Behavioral modification and serotonin-enhancing pharmacologic agents offer potential future treatment avenues.